Quaterly Results | Sakar Healthcare Ltd. | R Wadiwala Securities Pvt Ltd
NIFTY11875.10  -14.30 (-0.12%)
SENSEX40289.10  -233.00 (-0.57%)
  • top gainers
  • top losers
  • top volume
  • top value
investments Associate Login Online Trading Login
  • indian indices
  • global indices

We are investment service provider for Buy stocks , Low Stocks Brokerage , Stocks Portfolio Management in Surat , NRI Investment in Stocks , Share Broking Surat , Stock Broking Surat , Advisory Services Surat and Competetive Stocks Brokerage. investment advisory, financial integrity and prompt services in the whole of South Gujarat.

L
equity
Home Markets & NewsCompany ProfileQuarterly Results

SAKAR HEALTHCARE LTD.

NSE : SAKARBSE : ISIN CODE : INE732S01012Industry : Pharmaceuticals & DrugsHouse : Private
BSE0.000 (0 %)
PREV CLOSE (Rs.) NA
OPEN PRICE (Rs.) 0.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 0
TODAY'S LOW / HIGH (Rs.)0.00 0.00
52 WK LOW / HIGH (Rs.)0 0
NSE87.951.35 (+1.56 %)
PREV CLOSE( Rs. ) 86.60
OPEN PRICE (Rs.) 86.55
BID PRICE (QTY) 87.05 (20)
OFFER PRICE (QTY) 87.80 (150)
VOLUME 3742
TODAY'S LOW / HIGH(Rs.) 80.25 88.90
52 WK LOW / HIGH (Rs.)45.7 96

Quarterly Results

Quarters
GO
Select year
Particulars
Jun 2020
Audited / UnAudited
UnAudited
Net Sales
201.48
Total Expenditure
154.67
PBIDT (Excl OI)
46.81
Other Income
2.33
Operating Profit
49.14
Interest
6.37
Exceptional Items
NA
PBDT
42.77
Depreciation
10.49
Profit Before Tax
32.28
Tax
6.41
Provisions and contingencies
NA
Profit After Tax
25.87
Extraordinary Items
NA
Prior Period Expenses
NA
Other Adjustments
NA
Net Profit
25.87
Minority Interest
NA
Shares of Associates
Other related items
Misc. Expenses Written off
NA
Consolidated Net Profit
25.86
Equity Capital
149.61
Face Value (IN RS)
10.00
Reserves
NA
Calculated EPS
1.73
Calculated EPS (Annualised)
6.91
No of Public Share Holdings
4056957.00
% of Public Share Holdings
27.12
 
NA
PBIDTM% (Excl OI)
23.23
PBIDTM%
24.39
PBDTM%
21.23
PBTM%
16.02
PATM%
12.84
 
Notes
ATTENTION INVESTORS|KYC|IPO|PROPRIETARY TRADING
Prevent Unauthorised transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors.    
CORPORATE OFFICE
address
  • 9/2003-4,
  • Vishnu Priya Limda Chowk
  • Main Road
  • Surat – 395 003.
fax us @ +91-261-6673537
email us @ info@rwadiwala.com

Feed Back  | Terms & Conditions  | SEBI  | FMC  | NSE  | BSE  | MCX  | NCDEX  | IRDA  |  AMFI  | Disclaimer  | Privacy Policy  | Careers | User Agreements  | Ethics Policy  | Investor Protection  |  Dos and Don'ts   |  Rights and Obligations   |  Uniform Risk Disclosure   |   Important Policies   |  To File A Complaint on SCORES   | Sitemap 

SEBI Regn No. BSE - CM/F&O, NSE - CM/F&O/CDS: INZ000187332 | SEBI PMS regn no.: INP000004045 | MCX & NCDEX SEBI Regn No.: INZ000080636 | CDSL DP ID: 12043100
| R Wadiwala Securities Pvt Ltd - CIN: U67120GJ2004PTC044324 | R Wadiwala Commodities Pvt Ltd - CIN: U51109GJ2007PTC050176

Compliance Officer - Email ID: compliance@rwadiwala.com | Contact No.: 0261-6673542

The Stock Exchange, Mumbai is not in any manner answerable, responsible or liable to any person or persons for any acts of omission or commission, errors, mistakes and/or violation, actual or perceived, by us or our partners, agents, associates etc., of any of the Rules, Regulations, Bye-laws of the Stock Exchange, Mumbai, SEBI Act or any other laws in force from time to time. The Stock Exchange, Mumbai is not answerable, responsible or liable for any information on this Website or for any services rendered by us, our employees, and our servants.

Investor Greivance Redressal at support@rwadiwala.com

Copyright © 2016 | All Rights Reserved. R.Wadiwala group.

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.